印度与欧洲人群脂质数量性状位点与心血管代谢疾病的关联研究
研究对3000名印度旁遮普锡克人进行516种脂质代谢物的全基因组关联分析,并在英国生物银行等欧洲和南亚队列中验证。共发现609个SNP-代谢物关联,其中33个为首次报道,孟德尔随机化提示LPC O-16:0与2型糖尿病存在因果关联,PC 38:4(C)可能对印度裔冠状动脉疾病有保护作用。
要点
- LPC O-16:0与2型糖尿病存在因果关联,其先导变异位于CD45。
- PC 38:4(C)对印度裔冠状动脉疾病的保护作用可能具有族裔特异性。
- 33个SNP-脂质代谢物关联为首次报道,3个为族裔特异性关联。
核心结论
- 印度裔人群的mGWAS揭示了心血管代谢疾病新的分子起源,提示潜在治疗通路。
- LPC O-16:0与2型糖尿病存在因果关联,先导变异位于CD45。
- PC 38:4(C)对印度裔冠状动脉疾病的保护作用可能为族裔特异性。
研究设计与样本
- 对3000名印度旁遮普锡克人进行516种脂质代谢物的mGWAS。
- 在英国生物银行等欧洲和南亚独立队列中进行多层重复验证。
主要发现
- 共识别609个SNP-代谢物关联,代表236对达到全基因组显著性的SNP-代谢物对。
- 36个SNP-脂质代谢物信号通过多重检验校正,其中33个为首次报道,3个为族裔特异性。
- 孟德尔随机化提示LPC O-16:0与2型糖尿病存在因果关联。
- PC 38:4(C)对印度裔冠状动脉疾病风险的保护作用可能与FADS1/2基因非翻译区变异有关。
关键数值与推荐
- 全基因组显著性阈值为p ≤ 5 × 10^-8。
- 多重检验校正后显著性阈值为p ≤ 1.92 × 10^-10。
临床怎么用
- CD45作为已用药靶点,支持LPC O-16:0通路在2型糖尿病防治中的转化潜力。
- FADS1/2区域变异与PC 38:4(C)的关联提示印度裔冠状动脉疾病风险分层需考虑族裔特异性。
局限性
- 缺乏来自印度的独立亚洲印度裔验证队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic mechanisms that predispose people to type 2 diabetes (T2D) and cardiovascular disease (CVD) remain poorly understood, partly because of a lack of sufficient data on non-European ethnic groups. Extending these evaluations to diverse cohorts is essential for gaining insights into the molecular pathways involved in disease development among human populations. In this study, we aimed to evaluate the genetic connection between the human lipidome and cardiometabolic disorders. We conducted a metabolite genome-wide association study (mGWAS) in a Punjabi population from India, along with multi-layer replication studies using the UK Biobank and other independent European and non-European cohorts. METHODS AND FINDINGS: We performed mGWAS using 516 lipid metabolites in 3,000 Punjabi Sikh individuals, and validation was performed in 1.13M Europeans and 15K individuals from Asian Indian ancestry using independent cohorts of the UK Biobank, GeneRISK, DIAMANT, PROMIS, and other studies. We identified 609 SNP-metabolite associations representing 236 SNP-metabolite pairs that attained genome-wide significance (p </= 5 × 10-8). Of the 36 SNP-lipid metabolite signals that survived multiple testing correction (p </= 1.92 × 10-10), 33 associations were not reported before, and 3 associations were confirmed to be ancestry-specific. Using colocalization analysis, polygenic risk scores, and Mendelian randomization approaches, we identified a causal association of LPC O-16:0 with T2D, represented by a lead variant in CD45, a key regulator of T- and B-cell antigen receptor signaling, and is already used as a therapeutic target. Another possible causal relationship of PC 38:4 (C) in protecting against coronary artery disease risk in Asian Indians, attributed to a variant in the untranslated region in the FADS1/2 genes, may be specific to ancestry and/or could not be confirmed in Europeans because of extensive pleiotropy in this region. The main limitation of this study was the absence of an independent validation cohort of Asian Indians from India. CONCLUSIONS: The mGWAS of Asian Indians offers new insights into the diverse molecular origins of cardiometabolic diseases and suggests potential pathways for innovative treatments. Our findings highlight the need for additional research on human lipidomics to better understand the downstream effects of the genome and its impact on cardiometabolic health.
引用
- Rout M, Aston CE, Duggirala R, et al. Identification of lipid quantitative trait loci linked with cardiometabolic disease in Asian Indians and Europeans: A genome-wide association study and Mendelian randomization. PLoS Med. 2026. PMID: 42024661. doi:10.1371/journal.pmed.1005039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。